The announcements were made at the American Association of Neurological Surgeons meeting in San Diego, the Kalamazoo, Mich.-based company said.
The newly launched Sonopet iQ system is designed to allow surgeons to fragment, emulsify and aspirate soft tissue and bone during complex cranial neurosurgery, spinal and ear, nose and throat procedures, Stryker said.
“Sonopet iQ truly is our mission coming to life: Together with our customers, we are driven to make healthcare better. Sonopet iQ would not have been possible without the extensive collaboration between our customers and our team. I’m looking forward to seeing Sonopet iQ used in surgery in the coming months. I’m confident it will reshape surgical experiences,” neurological biz GM Jim Marucci said in a prepared statement.
In a separate release, Stryker said that it launched its SpineMap Go, an intraoperative image guidance system designed for spinal surgery. The system combines live, navigated instrumentation with fluoroscopic views without the need for a special imaging device.
The company said that the SpineMap Go can be easily integrated into standard fluoroscopic C-arms, and that it features instant registration and re-registration if accuracy is compromised.
“SpineMap Go will enable our customers to enjoy the benefits of advanced guidance without significant changes to their workflow, all with a reduction in the risks associated with radiation. We know our customers have been looking forward to this streamlined solution,” advanced guidance tech biz GM Lisa Kloes said in a press release.
Last week, Stryker said that it launched its Lifepak CR2 defibrillator featuring the LifelinkCentral AED program manager after winning FDA premarket approval for the system.